跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MG-121
首页
药物
MG-121
MG-121
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Moxifloxacin hydrochloride glucose injection and preparation method and use thereof
CN 101836950 A
申请人: SHAANXI SYNTHETIC PHARMACEUTICAL CO LTD
优先权: 2010
CN
Ibuprofen sodium chloride injection preparation with pH of 6.0-6.5, and preparation method thereof
CN 103565733 A
申请人: NANJING DIYI MEDICAL TECHNOLOGY CO LTD
优先权: 2012
CN
Stable rocuronium injection preparation and preparation method thereof
CN 103462885 A
申请人: HEBEI KINGSCI PHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2013
CN
种含有利奈唑胺的组合物及其制备方法
CN 104784113 B
申请人: 成都国为生物医药有限公司
优先权: 2015
CN
Production technology of ambroxol hydrochloride injection
CN 110237030 A
申请人: HUARUN SHUANGHE LIMIN PHARMACEUTICAL JINAN CO LTD
优先权: 2019
CN
Levofloxacin injection and preparation technology
CN 110755374 A
申请人: NANJING ZHIHE PHARMACEUTICAL TECH CO LTD
优先权: 2019
CN
Cepharanthine hydrochloride injection
CN 113855627 A
申请人: INST MILITARY MEDICINE ACADEMY MILITARY SCIENCES PLA
优先权: 2020
CN
Novel preparation method of phloroglucinol injection
CN 114668716 A
申请人: IGNITION POINT NANJING BIOMEDICAL SCIENCE AND TECH LIMITED COMPANY
优先权: 2020
CN
Stable parenteral composition of lacosamide
US 11278634 B1
申请人: EXTROVIS AG
优先权: 2021
US
Preparation of l-corydalmine injection
CN 113456585 A
申请人: NANJING ZEHENG PHARMACEUTICAL SCIENCE & TECH CO LTD
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈